Literature DB >> 24027290

Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.

Benjamin Kolisnyk1, Mohammed A Al-Onaizi, Pedro H F Hirata, Monica S Guzman, Simona Nikolova, Shahar Barbash, Hermona Soreq, Robert Bartha, Marco A M Prado, Vania F Prado.   

Abstract

One of the key brain regions in cognitive processing and executive function is the prefrontal cortex (PFC), which receives cholinergic input from basal forebrain cholinergic neurons. We evaluated the contribution of synaptically released acetylcholine (ACh) to executive function by genetically targeting the vesicular acetylcholine transporter (VAChT) in the mouse forebrain. Executive function was assessed using a pairwise visual discrimination paradigm and the 5-choice serial reaction time task (5-CSRT). In the pairwise test, VAChT-deficient mice were able to learn, but were impaired in reversal learning, suggesting that these mice present cognitive inflexibility. Interestingly, VAChT-targeted mice took longer to reach criteria in the 5-CSRT. Although their performance was indistinguishable from that of control mice during low attentional demand, increased attentional demand revealed striking deficits in VAChT-deleted mice. Galantamine, a cholinesterase inhibitor used in Alzheimer's disease, significantly improved the performance of control mice, but not of VAChT-deficient mice on the 5-CSRT. In vivo magnetic resonance spectroscopy showed altered levels of two neurochemical markers of neuronal function, taurine and lactate, suggesting altered PFC metabolism in VAChT-deficient mice. The PFC of these mice displayed a drastic reduction in the splicing factor heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2/B1), whose cholinergic-mediated reduction was previously demonstrated in Alzheimer's disease. Consequently, several key hnRNPA2/B1 target transcripts involved in neuronal function present changes in alternative splicing in VAChT-deficient mice, including pyruvate kinase M, a key enzyme involved in lactate metabolism. We propose that VAChT-targeted mice can be used to model and to dissect the neurochemical basis of executive abnormalities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24027290      PMCID: PMC6705170          DOI: 10.1523/JNEUROSCI.1933-13.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  92 in total

1.  Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.

Authors:  J Pfeuffer; I Tkác; S W Provencher; R Gruetter
Journal:  J Magn Reson       Date:  1999-11       Impact factor: 2.229

2.  Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation.

Authors:  T M Gill; M Sarter; B Givens
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

3.  Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filtering.

Authors:  R Bartha; D J Drost; P C Williamson
Journal:  NMR Biomed       Date:  1999-06       Impact factor: 4.044

4.  Spectroscopic lineshape correction by QUECC: combined QUALITY deconvolution and eddy current correction.

Authors:  R Bartha; D J Drost; R S Menon; P C Williamson
Journal:  Magn Reson Med       Date:  2000-10       Impact factor: 4.668

5.  Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla.

Authors:  R Bartha; D J Drost; R S Menon; P C Williamson
Journal:  Magn Reson Med       Date:  2000-08       Impact factor: 4.668

6.  Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

Authors:  A J Grottick; G A Higgins
Journal:  Behav Brain Res       Date:  2000-12-20       Impact factor: 3.332

7.  Increases in cortical acetylcholine release during sustained attention performance in rats.

Authors:  A M Himmelheber; M Sarter; J P Bruno
Journal:  Brain Res Cogn Brain Res       Date:  2000-06

8.  Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats.

Authors:  J McGaughy; M W Decker; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1999-05       Impact factor: 4.530

Review 9.  Attention and executive deficits in Alzheimer's disease. A critical review.

Authors:  R J Perry; J R Hodges
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

10.  Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress.

Authors:  S Du Yan; Y Zhu; E D Stern; Y C Hwang; O Hori; S Ogawa; M P Frosch; E S Connolly; R McTaggert; D J Pinsky; S Clarke; D M Stern; R Ramasamy
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

View more
  24 in total

1.  Exposure to mission relevant doses of 1 GeV/Nucleon (56)Fe particles leads to impairment of attentional set-shifting performance in socially mature rats.

Authors:  Richard A Britten; Leslie K Davis; Jessica S Jewell; Vania D Miller; Melissa M Hadley; Larry D Sanford; Mayumi Machida; György Lonart
Journal:  Radiat Res       Date:  2014-07-16       Impact factor: 2.841

Review 2.  The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Authors:  M Hvoslef-Eide; A C Mar; S R O Nilsson; J Alsiö; C J Heath; L M Saksida; T W Robbins; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

Review 3.  Neural circuitry and immunity.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 4.  Cholinergic modulation of the hippocampal region and memory function.

Authors:  Juhee Haam; Jerrel L Yakel
Journal:  J Neurochem       Date:  2017-08       Impact factor: 5.372

5.  Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions.

Authors:  Ryan T Muir; Benjamin Lam; Kie Honjo; Robin D Harry; Alicia A McNeely; Fu-Qiang Gao; Joel Ramirez; Christopher J M Scott; Anoop Ganda; Jiali Zhao; X Joe Zhou; Simon J Graham; Novena Rangwala; Erin Gibson; Nancy J Lobaugh; Alex Kiss; Donald T Stuss; David L Nyenhuis; Byung-Chul Lee; Yeonwook Kang; Sandra E Black
Journal:  Stroke       Date:  2015-09-17       Impact factor: 7.914

6.  α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation.

Authors:  Benjamin Kolisnyk; Mohammed A Al-Onaizi; Vania F Prado; Marco A M Prado
Journal:  Br J Pharmacol       Date:  2015-09-22       Impact factor: 8.739

7.  A novel mouse model of the aged brain: Over-expression of the L-type voltage-gated calcium channel CaV1.3.

Authors:  Jamie N Krueger; Shannon J Moore; Rachel Parent; Brandon C McKinney; Amy Lee; Geoffrey G Murphy
Journal:  Behav Brain Res       Date:  2016-06-28       Impact factor: 3.332

8.  Preferential cholinergic excitation of corticopontine neurons.

Authors:  Arielle L Baker; Ryan J O'Toole; Allan T Gulledge
Journal:  J Physiol       Date:  2018-02-20       Impact factor: 5.182

Review 9.  Let's call the whole thing off: evaluating gender and sex differences in executive function.

Authors:  Nicola M Grissom; Teresa M Reyes
Journal:  Neuropsychopharmacology       Date:  2018-08-14       Impact factor: 7.853

10.  Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndrome.

Authors:  Adi Aran; Reeval Segel; Kota Kaneshige; Suleyman Gulsuner; Paul Renbaum; Scott Oliphant; Tomer Meirson; Ariella Weinberg-Shukron; Yair Hershkovitz; Sharon Zeligson; Ming K Lee; Abraham O Samson; Stanley M Parsons; Mary-Claire King; Ephrat Levy-Lahad; Tom Walsh
Journal:  Neurology       Date:  2017-02-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.